Senseonics Holdings (SENS) Cash & Equivalents (2014 - 2026)
Senseonics Holdings' (SENS) quarterly Cash & Equivalents came in at $29.6 million in Q1 2026, down 24.67% year-on-year from $39.3 million in Q1 2025, and down 26.4% on a QoQ basis from $40.2 million in Q4 2025.
Senseonics Holdings (SENS) Cash & Equivalents (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 13 years of Cash & Equivalents data on file, last reported at $29.6 million in Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 24.67% year-over-year to $29.6 million in Q1 2026; TTM through Mar 2026 was $29.6 million, a 24.67% decrease from a year earlier, with the FY2025 full-year figure at $40.2 million, down 46.06% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $29.6 million, down from $40.2 million in the prior quarter.
- Over the last five years, Cash & Equivalents for SENS reached as high as $163.0 million in Q3 2022 and fell as low as $1.1 million in Q4 2022.
- Historically, Cash & Equivalents has averaged $80.7 million across 5 years, with a median of $75.7 million in 2023.
- Across the five-year window, Cash & Equivalents soared 6570.4% in 2023 and plunged 78.38% in 2024, its largest moves.
- Year by year, Cash & Equivalents stood at $1.1 million in 2022, then surged by 6570.4% to $75.7 million in 2023, then declined by 1.47% to $74.6 million in 2024, then slumped by 46.06% to $40.2 million in 2025, then slipped by 26.4% to $29.6 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $29.6 million in Q1 2026, $40.2 million in Q4 2025, and $34.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | Senseonics Holdings | 203.54 Mn | 139.22 Mn | 6.94 Mn | 29.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.61 Mn |
| Dec 31, 2025 | 40.23 Mn |
| Sep 30, 2025 | 34.46 Mn |
| Jun 30, 2025 | 126.40 Mn |
| Mar 31, 2025 | 39.31 Mn |
| Dec 31, 2024 | 74.60 Mn |
| Sep 30, 2024 | 27.11 Mn |
| Jun 30, 2024 | 84.60 Mn |
| Mar 31, 2024 | 98.70 Mn |
| Dec 31, 2023 | 75.71 Mn |
| Sep 30, 2023 | 125.40 Mn |
| Jun 30, 2023 | 125.10 Mn |
| Mar 31, 2023 | 136.60 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 163.00 Mn |
| Jun 30, 2022 | 150.50 Mn |
| Mar 31, 2022 | 39.01 Mn |
| Dec 31, 2021 | 4.26 Mn |
| Sep 30, 2021 | 46.21 Mn |
| Jun 30, 2021 | 69.75 Mn |